Coronavirus Notebook: Fauci Calls For Restraint In Disclosing Early Data; Bipartisan Lawmakers Want Warp Speed Audit

Dispatches from a world turned upside down also include the conditional approval of remdesivir in South Korea.

ImageFlow/Shutterstock.com

Requiring developers of COVID-19 vaccine candidates to refrain from issuing press releases on early looks at clinical data is a good idea but likely impractical, National Institute of Allergy and Infectious Diseases director Anthony Fauci said.

During a JAMA Live Stream interview on 3 August, JAMA editor Howard Bauchner said that as vaccines are starting to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Pink Sheet